Financiere de Tubize SA

FTD

Company Profile

  • Business description

    Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

  • Contact

    Allee de la Recherche, 60
    Brussels1070
    BEL

    T: +32 497515208

    https://www.financiere-tubize.be

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    250

Stocks News & Analysis

stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.
stocks

Undervalued ASX share upgrades guidance

Market share gains drive earnings upgrade despite a weak US housing backdrop.
stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,112.0079.700.88%
CAC 408,452.4046.340.55%
DAX 4025,519.71158.680.63%
Dow JONES (US)52,210.08262.830.51%
FTSE 10010,791.069.310.09%
HKSE25,278.7071.520.28%
NASDAQ24,932.0843.74-0.18%
Nikkei 22562,364.922,566.27-3.95%
NZX 50 Index13,861.9311.240.08%
S&P 5007,413.181.200.02%
S&P/ASX 2008,947.8085.600.97%
SSE Composite Index3,813.3144.93-1.16%

Market Movers